Brokerages Set Celcuity Inc. (NASDAQ:CELC) Price Target at $30.17

Celcuity Inc. (NASDAQ:CELC - Get Free Report) has been assigned an average rating of "Buy" from the seven brokerages that are covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $30.17.

A number of equities research analysts recently commented on CELC shares. HC Wainwright reaffirmed a "buy" rating and set a $27.00 target price on shares of Celcuity in a report on Tuesday, April 1st. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 target price on shares of Celcuity in a research report on Friday, April 11th.

Hedge Funds Weigh In On Celcuity

Several institutional investors have recently bought and sold shares of the company. Soleus Capital Management L.P. increased its stake in shares of Celcuity by 106.0% during the fourth quarter. Soleus Capital Management L.P. now owns 2,565,087 shares of the company's stock worth $33,577,000 after acquiring an additional 1,319,700 shares during the period. Baker BROS. Advisors LP raised its stake in shares of Celcuity by 42.9% during the 4th quarter. Baker BROS. Advisors LP now owns 2,678,553 shares of the company's stock worth $35,062,000 after buying an additional 803,575 shares in the last quarter. State Street Corp raised its stake in shares of Celcuity by 152.2% during the 3rd quarter. State Street Corp now owns 1,107,415 shares of the company's stock worth $16,512,000 after buying an additional 668,318 shares in the last quarter. Janus Henderson Group PLC acquired a new stake in shares of Celcuity in the 4th quarter valued at approximately $8,468,000. Finally, Candriam S.C.A. purchased a new stake in shares of Celcuity in the fourth quarter valued at approximately $3,450,000. 63.33% of the stock is owned by institutional investors and hedge funds.

Celcuity Stock Up 1.2 %

Shares of CELC stock traded up $0.14 during mid-day trading on Thursday, hitting $11.23. 34,041 shares of the stock traded hands, compared to its average volume of 298,160. The stock's fifty day moving average is $10.10 and its two-hundred day moving average is $12.14. The company has a debt-to-equity ratio of 0.65, a current ratio of 10.35 and a quick ratio of 10.36. Celcuity has a 52-week low of $7.58 and a 52-week high of $19.77. The stock has a market cap of $424.74 million, a P/E ratio of -4.30 and a beta of 0.44.

Celcuity (NASDAQ:CELC - Get Free Report) last posted its quarterly earnings data on Monday, March 31st. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.72) by ($0.13). Equities analysts predict that Celcuity will post -2.62 EPS for the current year.

Celcuity Company Profile

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.